Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIV drug maker gets SEC's 'goat' in insider trading scam

This article was originally published in Scrip

Executive Summary

Executives of a small publicly traded biotech in San Diego, California, got the US government's goat after routinely authorizing public securities filings that told investors "tall tales" about the status of the company's single drug candidate that was far different from reality, Securities and Exchange Commission (SEC) officials said, in charging those company managers with fraud and insider trading.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC013953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel